Skip to main content
. 2011 Jan 3;8(1):39–47. doi: 10.7150/ijms.8.39

Figure 4.

Figure 4

The representative m/z peaks at 6111 and 7978 in different stage CRC patients with DUKES A and Patients with DUKES B DUKES C and DUKES D. This data suggested that in different stages of CRC patients, there could be differential regulation of biomarkers, and some of them could diminish in late stages.